Fengping Tan ——Associate Professor |
|
|
Nationality:
|
CHINA
|
|
Phone:
|
022-27405160
|
|
Email:
|
tanfengping@163.com
|
|
Office:
|
Room 412-4, Building 24, Tianjin University
|
|
School:
|
School of Pharmaceutical Science and Technology
|
|
ResearcherID:
|
|
| 2002 | Ph. D. | W. China Center of Medical Sciences, Sichuan U., C |
| 2004 | Postdoctoral | Tsinghua University, China |
| Yu, M.; Ma H.; Lei M.; Li N.; Tan F. In vitro/in vivo characterization of nanoemulsion formulation of metronidazole with improved skin targeting and anti-rosacea properties. Eur. J. Pharmaceut. Biopharmaceut. 2014, 88, 92. |
| Wang, J.; Guo, F.; Ma,M.; Li,N.; Tan, F. Development of ketoconazole nanovesicular system using 1,2-hexanediol and 1,4-cyclohexanediol for dermal targeting delivery: physicochemical characterization and in vitro/in vivo evaluation. J. Nanopart. Res. 2014, 16, 2505. |
| Li, N.; Jia, W.; Zhang Y.; Zhang, M. C.; Tan, F.; Zhang, J. Effect of Hydrocarbon Chain Length in 1,2-Alkanediols on Percutaneous Absorption of Metronidazole: Toward Development of a General Vehicle for Controlled Release. AAPS Pharmscitech. 2014, 15, 354. |
| Li, S.; Wan, S.; Liang, Q.; Tan, F.; Li, N. Development and validation of a stability indicating capillary electrophoresis method for the determination of risedronate in tablets. J. Liq. Chromatogr. & Rel. Tech. 2013, 36, 1054. |
| Wan, S.; Sun, Y.; Sun, L.; Tan, F. Chitosan microparticles for oral bioavailability improvement of the hydrophobic drug curcumin. Pharmazie 2012, 67, 525. |
| Year | Title | Author(s) | Source | Volume |
|---|---|---|---|---|
